{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:59:11Z","timestamp":1791939551668,"version":"4.3.4"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T00:00:00Z","timestamp":1434326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0130083","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T18:28:44Z","timestamp":1434392924000},"page":"e0130083","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323"],"prefix":"10.1371","volume":"10","author":[{"given":"Kristen M.","family":"Bullard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah C.","family":"Gullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jordan","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Geiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,6,15]]},"reference":[{"key":"ref1","year":"2014"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.ijantimicag.2010.06.018","article-title":"Update on the global spread of dengue","volume":"36","author":"A Guzman","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"ref3","author":"FX Heinz","year":"2000"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.micro.56.012302.160654","article-title":"The molecular biology of West Nile Virus: a new invader of the western hemisphere","volume":"56","author":"MA Brinton","year":"2002","journal-title":"Annu Rev Microbiol"},{"key":"ref5","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"CM Rice","year":"1985","journal-title":"Science"},{"key":"ref6","article-title":"Fields virology","author":"B Lindenbach","year":"2007"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4155\/fmc.09.27","article-title":"Focus on flaviviruses: current and future drug targets","volume":"2","author":"BJ Geiss","year":"2009","journal-title":"Future Med Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2008.04.026","article-title":"Separate molecules of West Nile virus methyltransferase can independently catalyze the N7 and 2'O methylations of viral RNA cap","volume":"377","author":"H Dong","year":"2008","journal-title":"Virology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1128\/JVI.02202-07","article-title":"West Nile virus methyltransferase catalyzes two methylations of the viral RNA cap through a substrate-repositioning mechanism","volume":"82","author":"H Dong","year":"2008","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1128\/JVI.00814-06","article-title":"West Nile virus 5'cap structure is formed by sequential guanine N-7 and ribose 2'O methylations by nonstructural protein 5","volume":"80","author":"D Ray","year":"2006","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1261\/rna.1609709","article-title":"The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure","volume":"15","author":"M Issur","year":"2009","journal-title":"RNA"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/JVI.76.2.525-531.2002","article-title":"Paired charge-to alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes","volume":"76","author":"KA Hanley","year":"2002","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1128\/JVI.72.9.7270-7279.1998","article-title":"Trans-complementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells","volume":"72","author":"AA Khromykh","year":"1998","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Teramoto T, Boonyasuppayakorn S, Handley M, Choi KH, Padmanabahn R (2014) Substitution of NS5 N-terminal domain of dengue virus type 2 RNA with type 4 domain caused impaired replication and emergence of adaptive mutants with enhanced fitness. J Biol Chem: Epub ahead of print.","DOI":"10.1074\/jbc.M114.584466"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1128\/JVI.00384-12","article-title":"Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme","volume":"86","author":"HJ Stahla-Beek","year":"2012","journal-title":"Virol J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/emboj\/21.11.2757","article-title":"An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization","volume":"21","author":"MP Egloff","year":"2002","journal-title":"EMBO"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1107\/S090744499700231X","article-title":"Crystallization of the RNA guanylyltransferase of Chlorella virus PBCV-1","volume":"53","author":"AJ Doherty","year":"1997","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0022-2836(90)90024-G","article-title":"Three-dimensional structure of the complex of guanylate kinase from yeast with its substrate GMP","volume":"211","author":"T Stehle","year":"1990","journal-title":"J Mol Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"12995","DOI":"10.1021\/bi990910x","article-title":"Three-dimensional structure of adenosylcobinamide kinase\/adenosylcobinamide phosphate guanylyltransferase (CobU) complexed with GMP: evidence for a substrate-induced transferase active site","volume":"38","author":"TB Thompson","year":"1999","journal-title":"Biochemistry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jmb.2007.07.005","article-title":"Structural and functional analysis of methylation and 5'-RNA sequence requirements of short capped RNAs by the methyltransferase domain of dengue virus NS5","volume":"372","author":"MP Egloff","year":"2007","journal-title":"J Mol Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jmb.2008.11.058","article-title":"Analysis of flavivirus NS5 methyltransferase cap binding","volume":"385","author":"BJ Geiss","year":"2009","journal-title":"J Mol Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"35638","DOI":"10.1074\/jbc.M400460200","article-title":"A structural basis for the inhibition of the NS5 dengue virus mRNA 2'-O-methyltransferase domain by ribavirin 5'triphosphate","volume":"279","author":"D Benarroch","year":"2004","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1128\/JVI.02704-06","article-title":"Structure and function of flavivirus NS5 methyltransferase","volume":"81","author":"Y Zhou","year":"2007","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/1087057111412183","article-title":"A high-throughput screening assay for the identification of flavivirus NS5 capping enzyme GTP-binding inhibitors: implications for antiviral drug development","volume":"16","author":"BJ Geiss","year":"2011","journal-title":"J Biomol Screen"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States","volume":"286","author":"RS Lanciotti","year":"1999","journal-title":"Science"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.intimp.2012.11.016","article-title":"Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity","volume":"15","author":"LA Mitchell","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/jm0004289","article-title":"Progress toward the development of a safe and effective agent for treating reentrant cardica arrhythmias: synthesis and evaluation of ibutilide analogues with enhanced metabolic stability and dininished proarrhythmic potential","volume":"44","author":"JB Hester","year":"2001","journal-title":"J Med Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.bmcl.2004.01.045","article-title":"The design and preparation of metabolically protected new arylpiperazine 5-HT1A ligands","volume":"14","author":"M Tandon","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/jm00389a008","article-title":"Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chromic cardiovasculat diseases","volume":"30","author":"PM Manoury","year":"1987","journal-title":"J Med Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1021\/jm0209331","article-title":"Structure-activity relationships of 1-alkyl-5-(3,4-dichlorophenyl)-5-[2-[(3-substituted)-1-azetidinyl]ethyl]-2-piperidones. 1. Selective antagonists of the neurokinin-2 receptor","volume":"45","author":"AR MacKenzie","year":"2002","journal-title":"J Med Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/jm000228x","article-title":"New diarylmethylpiperazines as potent and selective nonpeptidic delta opiod receptor agonists with increased in vitro metabolic stability","volume":"43","author":"N Plobeck","year":"2000","journal-title":"J Med Chem"},{"key":"ref32","author":"L Di","year":"2008"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/jm010975+","article-title":"Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols","volume":"45","author":"JL Peglion","year":"2002","journal-title":"J Med Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","article-title":"Predicting plasma protein binding of drugs: a new approach","volume":"64","author":"NA Kratochwil","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Fessey RE, Austin RP, Barton P, Davis AM, Wenlock MC (2006) The role of plasma protein binding in drug discovery. Pharmacokinetic profiling in drug research: biological, physicochemical, and computational strategies. Zurich, Switzerland: LogP2004, Lipophilicity Symposium. pp. 119\u2013141.","DOI":"10.1002\/9783906390468.ch8"},{"key":"ref36","first-page":"330","article-title":"Solubility principles and practices for parenteral drug dosage form development","volume":"50","author":"S Sweetana","year":"1996","journal-title":"PDA Journal of Pharmaceutical Science and Technology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems","volume":"11","author":"CW Pouton","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"CW Pouton","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2217\/nnm.14.41","article-title":"A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications","volume":"9","author":"JR Lakkakula","year":"2014","journal-title":"Nanomedicine (London)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0130083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T13:44:32Z","timestamp":1599140672000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0130083"}},"subtitle":[],"editor":[{"given":"Robyn S","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,15]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0130083","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,15]]}}}